Association of short-chain fatty acids and the gut microbiome with type 2 diabetes: Evidence from the Henan Rural Cohort
Yang T, Wu C, Li Y, et al.
NMCD. Pub. online 13 Mar 2024.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
An exploratory analysis of the cost-effectiveness of insulin glargine 300 units/mL versus insulin glargine 100 units/mL over a lifetime horizon using the BRAVO diabetes model
Shao H, Shi L, Fonseca V, et al.
Diabet Med. 2024;e15303.
Leggi
The difference between Cystatin C- and Creatinine-based estimated glomerular filtration rate and risk of diabetic microvascular complications among adults with diabetes: A population-based cohort study
He D, Gao B, Wang J, et al.
Diabetes Care. 2024;dc232364.
Leggi
Associations of kidney tubular biomarkers with incident macroalbuminuria and sustained low eGFR in DCCT/EDIC
Limonte CP, Gao X, Bebu I, et al.
Diabetes Care. 2024;dc232196.
Leggi
Relationship of device measured physical activity type and posture with cardiometabolic health markers: pooled dose-response associations from the Prospective Physical Activity, Sitting and Sleep Consortium
Ahmadi MN, Blodgett JM, Atkin AJ, et al.
Diabetologia. Pub. online 13 Mar 2024.
Leggi
Efficacy of 1-hour postload plasma glucose as a suitable measurement in predicting type 2 diabetes and diabetes-related complications: A post hoc analysis of the 30-year follow-up of the Da Qing IGT and Diabetes Study
Peng M, He S, Wang J, et al.
Diabetes Obes Metab. Pub. online 15 Mar 2024.
Leggi
Lifetime and 10-year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE-T1D model
Helmink MAG, Hageman SHJ, Eliasson B, et al.
Diabetes Obes Metab. Pub. online 8 Mar 2024.
Leggi
The association between previous use of anti-obesity medication and semaglutide weight loss outcomes
Ghusn W, Fansa S, Anazco D, et al.
Diabetes Obes Metab. Pub. online 12 Mar 2024.
Leggi
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial
Brown DM, Boyer DS, Do DV, et al.
Lancet. 2024;S0140-6736(23)02577-1.
Leggi
Use of once-daily oral semaglutide and associated clinical outcomes among adults with type 2 diabetes in routine clinical practice in Canada: A multicentre, prospective real-world study (PIONEER REAL Canada)
Jain AB, Reichert SM, Amadid H, et al.
Diabetes Obes Metab. Pub. online 11 Mar 2024.
Leggi